Good article Kate,
The Pfizer pill is by all reports a good effective treatment, though for some reason Pfizer have said they can only produce 200 million doses in 2022. Not sure why, it is obviously difficult to produce for some reason, Merck have been having issues with theirs, I think with Omicron. I posted an article a while back.
There were always going to be competitors and this could be good for Pharmaust as CEO's from other big pharma's may be wary of Pfizer getting a head start and be tempted to try and buy a drug that proves it self in a clinical trial.
Fingers crossed. It only takes 1 CEO to say yes and if 2 say yes, you have a auction.
Pete
PAA 2022 , Human Trials , Covid , MND , Oncology , HVTL-1, K9 Phase III, page-263
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
21.0¢ |
Change
0.015(7.69%) |
Mkt cap ! $93.45M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 21.5¢ | 19.5¢ | $459.0K | 2.222M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103700 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.5¢ | 127225 | 3 |
View Market Depth
| Last trade - 16.10pm 11/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |